ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BSGM BioSig Technologies Inc

0.76
0.03 (4.11%)
Pre Market
Last Updated: 06:16:41
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
BioSig Technologies Inc BSGM NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.03 4.11% 0.76 06:16:41
Open Price Low Price High Price Close Price Previous Close
0.73
more quote information »

Recent News

Date Time Source Heading
3/11/202408:00EDGAR2Form 8-K - Current report
3/04/202419:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/28/202408:00EDGAR2Form 8-K - Current report
2/20/202409:00GLOBEBioSig Announces Reduction of its Workforce
2/14/202414:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/06/202407:35EDGAR2Form 8-K - Current report
2/06/202407:30GLOBEBioSig’s PURE EP™ Platform with New Near Field Tracking..
2/02/202416:18EDGAR2Form 8-K/A - Current report: [Amend]
2/01/202416:25EDGAR2Form 8-K - Current report
1/31/202415:05EDGAR2Form 8-K - Current report
1/31/202410:15GLOBEBioSig Announces Reverse Stock Split
1/30/202407:52EDGAR2Form 8-K - Current report
1/30/202407:30GLOBEBioSig Announces Cost Reductions to Improve its Financial..
1/16/202415:15EDGAR2Form D - Notice of Exempt Offering of Securities
1/12/202416:28EDGAR2Form 8-K - Current report
1/08/202410:00EDGAR2Form 8-K - Current report
1/05/202415:16EDGAR2Form S-3/A - Registration statement under Securities Act of..
1/04/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/29/202312:37EDGAR2Form DEL AM - Delaying amendment
12/28/202315:30EDGAR2Form 8-K - Current report
12/28/202315:05EDGAR2Form S-3 - Registration statement under Securities Act of..
12/22/202315:30EDGAR2Form 8-K - Current report
12/18/202315:36EDGAR2Form 8-K - Current report
12/06/202316:07EDGAR2Form 8-K - Current report
12/06/202313:20GLOBEBioSig Issues Letter to Shareholders Detailing Technology..
12/05/202316:29EDGAR2Form 8-K - Current report
12/04/202319:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/04/202318:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202308:13EDGAR2Form DEF 14A - Other definitive proxy statements
11/21/202316:32EDGAR2Form PRE 14A - Other preliminary proxy statements
11/14/202316:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202316:02EDGAR2Form 8-K - Current report
11/13/202315:30GLOBEBioSig Announces $2.5 Million Registered Direct Offering..
11/13/202307:35EDGAR2Form 8-K - Current report
11/09/202307:00GLOBEBioSig Announces $2.5 Million Registered Direct Offering..
11/08/202315:05EDGAR2Form 8-K - Current report
11/07/202307:01EDGAR2Form 8-K - Current report
11/07/202307:00GLOBEBioSig Appoints Global MedTech Leader Fred Hrkac as New..
11/03/202315:32EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/03/202315:30EDGAR2Form DEF 14A - Other definitive proxy statements
11/02/202307:00EDGAR2Form 8-K - Current report
11/02/202307:00GLOBEBioSig’s New PURE EP™ Subscription Model Adopted by Mayo..
11/02/202306:17EDGAR2Form 8-K - Current report
11/01/202307:35EDGAR2Form 8-K - Current report
11/01/202307:30GLOBEBioSig Adds Five New Patent Awards to 100+ Total Patent..
10/24/202315:30EDGAR2Form PRE 14A - Other preliminary proxy statements
10/16/202316:00EDGAR2Form 8-K - Current report
9/27/202316:01EDGAR2Form 8-K - Current report
9/15/202315:54EDGAR2Form 8-K - Current report
9/15/202315:52EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]

Your Recent History

Delayed Upgrade Clock